Flutoprazepam: Difference between revisions
From Drugwiki
m 1 revision imported |
m 1 revision imported |
| (One intermediate revision by the same user not shown) | |
(No difference)
| |
Latest revision as of 15:18, 29 October 2025
Flutoprazepam is a benzodiazepine derivative. It was discovered in Japan in 1972, and its mostly confined to that country even today. Flutoprazepam is around four times more potent by weight compared to diazepam.
Flutoprazepam
| |
| Systematic (IUPAC) name | |
| 7-chloro-1-cyclopropylmethyl-1,3-dihydro-5-(2-fluorophenyl)-2H-1,4-benzodiazepin-2-one | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C19H16ClFN2O |
| Mol. mass | 342.795 |
| Pharmacokinetic data | |
| Bioavailability | 80-90% |
| Metabolism | Hepatic |
| Half life | 60-90 hours |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
X(US) |
| Legal status |
Schedule IV(US) |
| Routes | Oral, Intravenous |
Abuse of benzodiazepines in Japan is extremely common, with flutoprazepam being one of the most commonly abused, along with the benzodiazepines of abuse nimetazepam, temazepam, and triazolam.